Navigation Links
Cambrex Reports Fourth Quarter and Full Year 2009 Results
Date:2/10/2010

============== ============== Twelve Months Twelve Months 2009 2008 -------------- -------------- Operating Profit, as Reported $26,638 $19,422 Depreciation and Amortization 20,505 21,055 Strat. Alt. & Restructuring Expenses* - 6,210 CEO Retirement** - 1,040 -------------- -------------- Adjusted EBITDA $47,143 $47,727 ============== ============== * During 2008, the Company incurred expenses related to restructuring activities and strategic alternative expenses pursuant to the sale of its Bioproducts and Biopharma businesses in February 2007 and for the consolidation of the New Jersey R&D facility. These costs are identified within the 2008 income statement and have been excluded from the calculation of certain profit measurements, including Adjusted EBITDA for 2008. ** During 2008, the Company incurred expenses related to the retirement of its former CEO. These costs are included within Selling, General and Adminis
'/>"/>
SOURCE Cambrex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cambrex Presentation at the JPMorgan Healthcare Conference to be Webcast
2. Cambrex to Announce Fourth Quarter and Full Year 2007 Financial Results on February 14, 2008
3. Cambrex Appoints Steven M. Klosk as President and CEO
4. Cambrex Reports Third Quarter 2008 Results
5. Cambrex Receives Notice Regarding NYSE Listing
6. Cambrex Reports First Quarter 2009 Results
7. Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. QMed, Inc. Reports July Medicare SNP Enrollments
10. Phlo Affiliate Reports Expanded Coverage to Oregon Border
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014 Genedata, a leading ... and life science research, today announced the ... be held in Asia, Europe, and North America ... companies and leading research organizations will gather for ... case studies, and upcoming challenges in all areas ...
(Date:8/26/2014)... CITY, Calif. , Aug. 26, 2014 /PRNewswire/ ... development and commercialization of oncology diagnostic products, has ... as a 2015 Technology Pioneer . As ... is one of 24 companies across a wide ... prestigious accolade. Guardant360 ® , ...
(Date:8/26/2014)... Cary, NC (PRWEB) August 26, 2014 ... built-in GMP processes, implemented a new pricing structure with ... better comply with cGMP and 21 CFR Part 11 ... Good Manufacturing Practices any way we can” said Rick ... the number of available users allowed customers to have ...
(Date:8/26/2014)... 26, 2014 Historically, drug development ... list continues to grow – high attrition rate, ... and development, high regulatory hurdles and increasing ... become clear that the traditional business model of ... are now seeking to find better ways to ...
Breaking Biology Technology:Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2Transitioning from Bench into Clinical Phase, new webinar hosted by Xtalks 2
... Verenium Corporation (Nasdaq: VRNM ), a ... today announced that it has entered into an agreement ... United States ("Ex-Im Bank") for two 18-month, secured revolving ... These new credit facilities will allow the Company ...
... 2011 PharmaVentures today announced the launch of ... Essential Deal Trends: Oncology 2011 . This new series ... and commercialising new drugs. The first report in the series ... active deal making therapeutic area in the pharmaceutical and biotechnology ...
... cell carcinomas are amongst the most frequent cancers in ... like many other human cancers, contain particular cancer cells, ... potential that sustain tumor growth. Little is known about ... High level of VEGF expression in skin cancer ...
Cached Biology Technology:Verenium Announces Up to $16 Million in New Secured Financings 2Verenium Announces Up to $16 Million in New Secured Financings 3Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 2Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 3New role for Vascular Endothelial Growth Factor in regulating skin cancer stem cells 2
(Date:8/25/2014)... Scientists have known that toxic effects of substances ... both natural and human-made materials, can pass from ... shows that females with ancestral exposure to EDC ... According to a new study by researchers from ... State University, male and female rats are affected ...
(Date:8/25/2014)... 133 active fires in the North Slave Region of the ... 24 hours. Fire danger is moderate to high. Smoke ... Lake Complex of fires are in an area approximately 80 ... north of Fort Providence. Four crews will be working ... week. Mop-up continues many areas of complex,s fire perimeter. The ...
(Date:8/25/2014)... a lightning strike on August 12, 2014. Currently the ... There are close to 2,000 personnel working on this ... and a number of large ones. Most of the ... 100 acres. An inversion layer settled over the fire ... keeping fire activity moderate. As the inversion lifted in the ...
Breaking Biology News(10 mins):Exposure to toxins makes great granddaughters more susceptible to stress 2Happy Camper and July Fire Complexes in California 2
... Va.Though many policymakers have argued that environmental regulations ... a new study by George Mason University researcher ... production processes can not only offset the costs ... The study, which looked at more than ...
... branch of Munich (Germany) based Genomatix Software GmbH, announced ... to provide Genomatix software and data content to Pfizer ... Pfizer are designed to show how genes are regulated ... the software and data content to help understand the ...
... International,Inc. (OTC Bulletin Board: BKYI), a leader in ... issued the following,open letter to its shareholders discussing ... performance., Highlights:, -- Revenue growth from ... in our installed base of law enforcement customers, ...
Cached Biology News:Corporations can profit from being environmentally friendly 2BIO-key(R) Issues Open Letter to Shareholders 2BIO-key(R) Issues Open Letter to Shareholders 3BIO-key(R) Issues Open Letter to Shareholders 4BIO-key(R) Issues Open Letter to Shareholders 5
...
...
... Formulation: 50mM Tris-HCl, pH 7.5, ... PMSF, 1mM benzamidine, 0.1% 2-mercaptoethanol ... (Protein Phosphatase 2A1) partially purified ... precipitation, QSepharose,amino-hexyl agarose, Superdex 200, ...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: